Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD initiation and calcineurin inhibitor minimization in heart transplant patients with renal impairment
2005-000222-22Phase 4Completed
- Sponsor
- Oligovax
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of cefradine in chronic kidney disease (CKD), sponsored by Oligovax. Primary endpoint: renal function. Started Jul 2005; status: completed.
02
Drugs
cefradine
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2005-000222-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000222-22.